Dec 20, 2017 - IIS Forecasting Basics. This document includes answers to questions raised during the Immunization Inform
Office of Immunization and Child Profile
IIS Monthly Training
IIS FORECASTING BASICS DECEMBER 20, 2017 FREQUENTLY ASKED QUESTIONS IIS Forecasting Basics This document includes answers to questions raised during the Immunization Information System monthly training on the IIS Forecasting Basics conducted on December 20, 2017. Question 1: If a patient is older than age seven years and on a catch up schedule, should they receive a Td or a DT vaccine? Answer 1: If a patient is older than age seven years, they should receive Tdap or Td, regardless of how many DTaP doses they received when they were younger than seven. Question 2: Is there an age limit for the Inactivated Polio Vaccine (IPV) when it is no longer recommended? Answer 2: The IPV vaccine is not recommended for healthy patients older than 18 years old living in the United States. If a patient is 18 years and older and hasn’t started the IPV series, then IPV isn’t recommended for this patient, unless the patient is at higher risk of polio infection. If a patient is older than age 18 years and started the IPV series before 18, the healthcare provider can consider completing the series for this patient, especially if the patient is at high risk for polio infection, may travel internationally as an adult, or may be required to get vaccinated for work. Question 3: How does the forecast work for patients who have started vaccinations in a different country and moved to the United States? Our clinic has several patients who started vaccinations in Canada and therefore received the Meningococcal C vaccine. How would these patients be forecasted? Answer 3: If a patient started with a Meningococcal C vaccine overseas, the forecast would accept the vaccination as valid, even though currently the United States does not have Meningococcal C recommendations. The regular forecast would not be altered, the Meningococcal Conjugate Vaccine (MCV) dose would still show as recommended with doses at 11 and 16 years of age. The IIS cannot document that a patient is high risk or has a high risk medical condition. However, the forecast does recognize when high risk doses of meningococcal or pneumococcal vaccines are given, and will forecast based on possible high risk doses that may be recommended for the patient. For people with disabilities, this document is available on request in other formats. To submit a request, please call 1-800-525-0127 (TDD/TTY call 711). DOH 348-673 December 2017
Office of Immunization and Child Profile
IIS Monthly Training
IIS FORECASTING BASICS DECEMBER 20, 2017 FREQUENTLY ASKED QUESTIONS Question 4: Once a patient is past the recommended age ranges, does Hib, PCV and Rotavirus drop from the patient’s forecast? Answer 4: Yes, once a patient is older than the recommended age range for the vaccine, the forecast will remove the recommendation. If a patient is high risk or there are other factors, the medical provider should use their clinical judgement in conjunction with the forecasting tool to determine which vaccines a patient needs.
For people with disabilities, this document is available on request in other formats. To submit a request, please call 1-800-525-0127 (TDD/TTY call 711). DOH 348-673 December 2017
